nephritis leading to ESRD [6] [7] [8] [9] [10] . Poor prognostic fac- vere renal lesions [11, 12] . It has been reported that follow-up of Ն3 years according to the slope of the creatinine growth factors such as platelet-derived growth factor and clearance against time, and in 221 patients with a follow-up of cytokines are responsible for the increased production Ն1 year assessing by univariate and multivariate analyses of of extracellular matrix contributing to the development renal survival. These associations were further estimated in a meta-analysis of seven studies retrieved in the Medline dataof glomerular sclerosis [13] . Angiotensin II modulates base. The meta-analysis was performed according to the Manthe local production of these mediators and consequently tel-Haenszel-Peto method when homogeneity of the studies induces mesangial cell proliferation, mesangial matrix was established using the 2 test by Breslow-Day.
production and progression of renal lesions [14] . In this reaction, a preferential amplification of the D allele and inefficiency in amplification of the I allele could generOne hundred and thirty-six patients had a follow-up of three or more years, while 221 had a follow-up of one or ate mistyping of the ID heterozygote as a DD homozygote [29] . For this reason, all samples found to be DD more years; the total mean follow-up was 5.3 Ϯ 5.2 years.
Blood samples were obtained from all patients after after amplification with the conventional primers were reamplified using primer pair recognized insertion-specific appropriate informed consent. All patients had serial measurements of serum creatinine, proteinuria, and sequences: 5Ј-TGG GAC CAC AGC GCC CGC CAC TAC-3Ј and 5Ј-TCG CCA GCC CTC CCA TGC CCA blood pressure. The serum creatinine concentration was determined by an autoanalyzer technique, using the TAA-3Ј. Only the I allele produced a 335 bp amplicon. The rate of false positives was 10% of the samples, which modified Jaffe method. Creatinine clearance (C Cr ) was calculated by using the Cockcroft formula. Urine protein is similar to that found by other investigators [20, 25] . Angiotensinogen gene polymorphism (AGT M235T) concentration was measured by the pirogallolo method. Proteinuria was classified as mild (Յ1 g/day), moderate was examined by a mutagenically separated PCR technique (MS-PCR) based on a three-primer one-step assay (Ͼ1 to 3 g/day) and severe (Ͼ3 g/day). The persistence of maximal level of proteinuria was considered for at (M235T1, 5Ј-CCA GGG TGC TGT CCA CAC TGG CTC CGG-3Ј; M235T2, 5Ј-AAG TGG ACG TAG GTG least six months during the follow-up period. Proteinuric patients were considered responsive to ACE inhibitors TTG AAA GGG AGG GTG CTG TCC ACA CTG GCT TCC-3Ј; M235T3, 5Ј-TGT GGT CCT CCC ACG therapy when a reduction of at least 50% of the baseline proteinuria was obtained. Hypertension was defined as CTC TCT TGG-3Ј), as previously designed [30] . Amplification with primer M235T1 and primer M235T3 systolic blood pressure higher than 140 mm Hg and diastolic blood pressure higher than 90 mm Hg. Hypertenyielded a 134 bp product representing the 235T allele, whereas amplification with primer M235T2 and primer sive patients were considered responsive to antihypertensive therapy when a reduction of blood pressure M235T3 yielded a 156 bp product, representing the M235 allele. below 140 to 90 mm Hg was obtained.
Two outcome measures of renal disease progression Statistical analysis were made in our population study. First, progression of the renal damage was evaluated in 136 patients according Allelic frequency was deduced from the genotype distribution. Analysis was performed by the 2 test on the to the slope of the creatinine clearance against the time distribution of ACE D/I genotype and allele frequencies sessed on the basis of the 2 test by Breslow-Day using between IgAN patients and controls, and between stable a significance level of P ϭ 0.05. Given the different allele renal function and deteriorating renal function in IgAN frequencies reported for healthy controls, separate analpatients. Linear regression analysis was performed to yses were performed for Caucasians and Asians. generate the rate of deterioration of C Cr over time. Univariate analysis of the renal survival was performed using the Kaplan-Meier technique for censored data. The in-RESULTS fluence of prognostic factors was assessed by univariate Population study (log-rank test) and multivariate analyses (Cox's proporIn our cohort of 247 IgAN patients, we studied the tional hazard methods). For the statistical analysis, we influence of the ACE genotype on the development of used the StatView 5.0 program (1992 to 1998; SAS InstiIgAN and the progression of renal disease. With regards tute Inc., Cary, NC, USA).
to the development of disease, Table 1 shows the distri-A meta-analysis of ACE genotype polymorphism studbution of the ACE genotypes and alleles in our IgAN ies in the development and progression of IgAN was perpatient population at the time of renal biopsy. The ACE formed using studies identified by the Medline database I/D genotype did not correlate with age ( 2 ϭ 0.63; P ϭ literature research feature from the publication of the first study [20] to May 1999. Abstracts, letters, and review 0.73) or gender ( 2 ϭ 4.19, P ϭ 0.12), and did not influarticles were not considered for this analysis. All seven ence the presence of hypertension ( 2 ϭ 3.29, P ϭ 0.14), retrieved articles were critically assessed for their meththe amount of daily proteinuria ( 2 ϭ 3.42, P ϭ 0.49), odological quality, with particular attention to the possiabnormal renal function ( 2 ϭ 1.1, P ϭ 0.58), or severity bility of bias in the selection of cases (biopsy-proven of renal lesions ( 2 ϭ 3.87, P ϭ 0.42). With regards to IgAN) and controls; clinical characteristics such as the dethe progression of renal disease, we studied the distribugree of proteinuria, blood pressure control and therapy; tion of the ACE genotypes and alleles in 136 IgAN definition of progression of renal damage; and type of patient population with a follow up Ն3 years. At the last statistical analyses. Each article was evaluated indepenfollow-up, the ACE I/D genotype did not influence blood dently by three investigators (two of whom were blinded pressure ( 2 ϭ 0.10, P ϭ 0.95) and persistent proteinuria to the name of the journal and the authors of the article) ( 2 ϭ 1.77, P ϭ 0.41). The ACE I/D genotype distribution using a scoring sheet to list those elements important for was identical in proteinuric IgAN patients responsive a meta-analysis [31] . The meta-analysis was performed and not responsive to therapy with ACE-inhibitors ( 2 ϭ according to the Peto method in which a 2 ϫ 2 table 0.87, P ϭ 0.65) and in hypertensive patients responsive was constructed for each candidate study [32] . This is a and not responsive to other antihypertensive drugs ( 2 ϭ modification of the Mantel-Haenszel method; by a sim-0.69, P ϭ 0.71). The ACE I/D genotype distribution ple set of operations, it allows weighted analyses for each was not different between 99 patients with stable renal study based on calculation of its inverse variance. In metafunction (average C Cr slope, 0.2 Ϯ 3.1) and 37 patients analysis graphical representation, the area of the black with deteriorating renal function (average C Cr slope, square indicates the amount of information contributed by each individual study and is inversely proportional to Ϫ9.1Ϯ 6.2; 2 ϭ 4.23, P ϭ 0.12). the standard error of the log of the odds ratio (OR).
The ten-year cumulative renal survival rate for cenThe main outcome measures of the meta-analysis were sored data (Kaplan-Meier) in 221 patients with a follow the development of IgAN and the deterioration of renal up Ն1 year was 73%; 46 patients reached the end point function, including the ESRD treated by dialysis or renal of ESRD. transplantation. Progression of renal damage was deUnivariate analysis of survival curves (log-rank test) fined as a decrease of renal function estimated by slope showed that serum creatinine (P Ͻ 0.0001), daily proteinof creatinine clearance against time [20, 26] , slope of the uria (P Ͻ 0.0001), histological grade (P Ͻ 0.0001), and reciprocal of serum creatinine [21], increase of initial blood pressure (P Ͻ 0.0001) were correlated with poor serum creatinine to a mean of 4.5 Ϯ 0.86 mg/dL [25], renal survival. Gender, age, and the AGT M235T and and occurrence of ESRD [24] . Genotype and allele fre-ACE genotypes did not influence the renal survival quencies were extracted, and the ORs were calculated.
( Fig. 1) . Multivariate analysis by Cox's proportional hazThe statistical analyses were performed on the distribuard model revealed that only serum creatinine (P ϭ tion of the DD ϩ ID versus II genotype. To test for the 0.0007; hazard ratio (HR) ϭ 3.4; 95% CI, 1.7 to 7), severe stability of the results, two additional approaches were proteinuria (P Ͻ 0.0001; HR ϭ 8.4; 95% CI, 3.3 to 21.2), performed on the distribution of the DD versus II ϩ ID and severe histological grade (P ϭ 0.02; HR ϭ 4.2; 95% genotypes and on allele frequency. The total OR and CI, 1.26 to 14.4) at the time of renal biopsy were indepen-95% confidence interval (CI) were calculated using Peto's odds ratio. Heterogeneity of the studies was asdently predictive of poor outcome. ESRD [24] . In our study, the distribution of genotype frequencies was identical to that of the other Caucasian studies [23, 24, 26]. We did not find a significant difference in our patients and controls ( 2 ϭ 0.38, P ϭ 0.83).
Epidemiological analysis
The mean frequency of DD, ID, and II genotypes in the IgAN patient population was significantly different from The distribution of ACE I\D genotype and alleles in that of the control population in Asian patients (IgAN our study and in seven retrieved articles are reported in DD ϭ 0.20, ID ϭ 0.40, II ϭ 0.40; control DD ϭ 0.11, Table 2 .
ID ϭ 0.46, II ϭ 0.43; 2 ϭ 6.6; P ϭ 0.04) but not in Number of patients and controls. Our study enrolled Caucasians (IgAN DD ϭ 0.37, ID ϭ 0.44, II ϭ 0.19; 247 IgAN patients and 205 controls, matched for age control DD ϭ 0.34, ID ϭ 0.48, II ϭ 0.18; 2 ϭ 3.87; and gender. Smaller sample sizes of IgAN patients and P ϭ 0.14). controls were used for the study of ACE gene polymorAllele frequency. In our study, the allele frequency phism by all investigators [20-23, 25], except for Schmidt was identical to that of other Caucasian studies, and et al [24] and Pei et al [26] .
there was no significant difference between the IgAN Race. In our study, Caucasian patients and controls patients and controls ( 2 ϭ 0.27; P ϭ 0.59). The mean were from Puglia region of South Italy, which has four distribution of D and I allele frequency in IgAN patients million inhabitants. In four studies in which Caucasians was not significantly different from that of normal popuwere included, patients came from Scotland Gender. In our study, the number of male patients Meta-analysis was higher than that of female patients with a ratio of
The current study plus seven articles [20-26] that satis-2.4 to 1, resembling the disease ratio. In three studies, fied the specific criteria listed in the statistical analysis the number of male patients was higher than that of section of this article were chosen for the meta-analysis. female patients [20, 22, 24- Table 2 ). Therefore, the Japanese and Caucasian Age. The mean age of our patients was 30 Ϯ 12 years population studies were analyzed separately. In total, (range 5-66 years), and 48 of them were younger than the Asian studies comprised 198 IgAN patients and 220 18 years of age. In the other studies, only adult patients controls, whereas Caucasian studies included 719 IgAN patients and 637 controls. were enrolled. Children, both boys and girls, were pres- Ethnicity was divided into two populations: Asian studies [20] [21] [22] and Caucasian studies [23] [24] [25] [26] . The populations were in Hardy-Weinberg equilibrium in all studies, except for those of Yoshida et al and Schmidt et al, that observed a significant difference respectively in the subgroup of patients with deteriorating renal function (P Ͻ 0.05) and in those with end-stage renal disease (P ϭ 0.04). ND is not described.
Results of meta-analysis in the development of 26 ] because the control group data were not reported in Hunley et al's study [25] . The total OR values and in the progression of renal disease are reported in Figures 2 and 3 . A pooled estimate was performed when were 0.95 (95% CI, 0.64 to 1.42) and 0.93 (95% CI, 0.71 to 1.23), respectively. the homogeneity of the studies was confirmed by the Breslow-Day 2 test (P not significant). Figure 2 shows Two additional approaches were used to investigate to what extent the D allele influenced the onset of the the meta-analysis of the ACE genotype polymorphism in IgAN patients compared to controls, evaluating the disease, by changing the classification of the exposure variable. Three different analyses are reported in Table  ORs of second, comparison of the DD versus ID ϩ II genotypes; did not reach a statistical significance. At the same time and third, the D versus I allele frequency. It is evident the significant OR value estimated in our study suggests that an increased risk with the homozygous DD genotype a paradoxical protective effect of the D allele, but the (96%) was present among Asians (OR, 1.96, 95% CI, meta-analysis of Caucasian population studies demon-1.13 to 3.41). In contrast, a very small risk without statististrated a total OR value of 1.12 (95% CI, 0.67 to 1.88). cal significance (17%) of IgAN was evident among CauThis indicates that there is no relationship between the casians (OR, 1.17, 95% CI, 0.94 to 1.46). D allele and the deterioration of renal function. Figure 3 shows the meta-analysis of the association between ACE D/I genotype polymorphism and deteriorat-DISCUSSION ing renal function in IgAN patients. The analysis in Asian Our study, which includes a cohort of patients with population was limited to one study [20] because no data biopsy-proven IgAN enrolled in a restricted area with a were available in the other studies. Even though the insufficient follow-up, shows no influence of the ACE I/D fluence of the D allele in deteriorating renal function was reported in this Japanese study [20] , the OR value of 2.26 gene polymorphism (genotype distribution and allele fre- Caucasian patients does not confirm the poor prognostic were analyzed separately for their renal function, the role of the DD genotype and D allele. This consideration DD genotype as well as the D allele was strictly associsuggests that association studies, performed in a wellated with the progressive decline of the renal function.
designed manner, should be done using large population The DD patients with normal renal function, no hypersamples of patients and controls. Recent studies docutension, and proteinuria at the time of renal biopsy had menting an increased risk of left ventricular hypertrophy a 7.5 times higher risk to develop progressive deteriorain subjects with the DD genotype [36, 37] and of netion of renal function than those who did not have this phropathy in DD insulin-dependent diabetes mellitus genotype [25] . They concluded that the DD genotype is [38] [39] [40] were not confirmed when large population studan independent risk factor for renal progression because ies were done or when pooled data analysis was applied D homozygous patients progressed independently of [33, [41] [42] [43] [44] . Recently, Japanese investigators reconsidproteinuria and hypertension, which are two important ered the effect of the ACE I/D gene in the progression risk factors responsible for poor renal prognosis. In an of renal damage in IgAN patients and they did not find effort to replicate these findings, we divided our large a significant correlation [45] . sample of IgAN patients with normal renal function at An important purpose of a meta-analysis is to help the time of renal biopsy into two groups, nonprogressors direct future research. Our findings suggest that addiand progressors to renal insufficiency, and found no assotional research into the association of genetic variability ciation with DD genotype. There are several explanaof the ACE and other genes and IgAN is warranted in tions for the discrepancy between our findings and the genetically homogeneous populations. For IgAN, which earlier observations. Previously published studies were is a multifactorial disease with several major susceptibillimited by their heterogeneously selected populations ity loci, the sample size required to replicate a linkage [20] [21] [22] [23] 25 ]. In addition, it has been pointed out that or association study to a specific locus should be larger there is considerable variability in the frequency of the than in previous studies. For this reason, it is useful to DD genotype among so-called controls in smaller studies organize a multicenter collaborative study to assemble and among populations [33] [34] [35] . In fact, we cannot exa large cohort of patients. The number of cases associatclude the possibility that DD genotype can influence ing an allele with a particular phenotype must be large enough to be convincing. IgAN development and progression of renal damage in
